SCHEMBL4979162

SCHEMBL4979162

CCC(CC)CN1C(=O)NC(=O)[C@@]12C(=O)Nc1ccc(C)cc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.42
CYP3A4 P08684 2/20 0.42
CYP2C19 P33261 2/20 0.42
POLB P06746 1/20 0.42
ALDH1A1 P00352 6/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
AKR1B1 P15121 1/20 0.39
ADAMTS5 Q9UNA0 4/20 0.36
GAA P10253 2/20 0.36
MGAM O43451 1/20 0.36
SI P14410 1/20 0.36
MGAM2 Q2M2H8 1/20 0.36
MAPT P10636 4/20 0.34
LMNA P02545 3/20 0.34
KDM4E B2RXH2 2/20 0.34
ALOX12 P18054 1/20 0.34
SMN1; SMN2 Q16637 3/20 0.34
TP53 P04637 2/20 0.33
USP2 O75604 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4979421 0.79 CYP1A2 (0.42) CYP1A2CYP3A4CYP2C19POLBALDH1A1
SCHEMBL4979964 0.79 CYP1A2 (0.42) CYP1A2CYP3A4CYP2C19POLBALDH1A1
SCHEMBL4974508 0.77 POLB (0.43) CYP1A2CYP3A4CYP2C19POLBALDH1A1
SCHEMBL3953438 0.74 CYP1A2 (0.43) CYP1A2CYP3A4CYP2C19POLBALDH1A1
SCHEMBL4979166 0.73 CYP1A2 (0.39) CYP1A2CYP3A4CYP2C19POLBALDH1A1
SCHEMBL4979292 0.72 CYP1A2 (0.43) CYP1A2CYP2C19KMT2AAKR1B1GAA
SCHEMBL4979612 0.72 TP53 (0.39) CYP1A2CYP3A4CYP2C19POLBALDH1A1
SCHEMBL4976840 0.71 POLB (0.37) CYP1A2CYP3A4CYP2C19POLBALDH1A1
SCHEMBL4977915 0.70 KDM4E (0.42) CYP1A2CYP3A4CYP2C19POLBALDH1A1
SCHEMBL16315854 0.67 PGR (0.56) CYP1A2CYP3A4CYP2C19POLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1984374-A1 USE OF SPIRO Ý IMIDAZOLIDINE-4, 3'-INDOLE¨2, 2', 5' (1H) TRIONES FOR TREATMENT OF CONDITIONS ASSOCIATED WITH VANILLOID RECEPTOR 1 AstraZeneca AB (SE) 2008-10-29 EP disclosed
WO-2007091946-A1 USE OF SPIRO [ IMIDAZOLIDINE-4, 3'-INDOLE] 2, 2', 5' (1H) TRIONES FOR TREATMENT OF CONDITIONS ASSOCIATED WITH VANILLOID RECEPTOR 1 ASTRAZENECA AB (SE) 2007-08-16 WO disclosed